arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Inogen Inc

INGN
$6.06 ▼ -0.41 (-6.34%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
57 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Inogen Inc faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $165.6M
Dividend Yield
Revenue Growth 3.4%
Op. Margin -11.0%
ROIC -5.0%
FCF / Share $-0.25
Trailing P/E
Price / Book 0.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

57-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$85.11M
↑ +3.4%
Net Income Profit after all expenses
$-8.32M
↓ -34.8%
Operating Margin Operating profit as % of sales
-11.0%
↑ +3.7% 16th
FCF / Share Free cash flow per share
$-0.25
↑ +62.8%
Long-Term Debt Long-term obligations
$80.00K
↓ -49.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
18
Returns
33
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 57 quarters